SecSonar.com

Sight Sciences, Inc. (SGHT)

Sight Sciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Sight Sciences, Inc. (SGHT) is a Medical - Devices company based in US with a market capitalization of $270.1M. Revenue declined 3.1% year-over-year and free cash flow was negative at -$29.9M. This page tracks SGHT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 216 employees · IPO Jul 15, 2021

Valuation

Valuation & price

$4.98 · as of May 17, 2026 · -45.0% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.22

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$9.05$6.13$3.20Jul 25Dec 25Jul 26Jul 7, 25$3.48Jul 9, 25$3.52Jul 11, 25$3.41Jul 15, 25$3.34Jul 17, 25$3.54Jul 21, 25$3.43Jul 23, 25$3.78Jul 25, 25$3.49Jul 29, 25$3.46Jul 31, 25$3.33Aug 4, 25$3.47Aug 6, 25$3.68Aug 11, 25$4.12Aug 13, 25$4.25Aug 15, 25$4.20Aug 19, 25$4.09Aug 21, 25$4.12Aug 25, 25$4.21Aug 27, 25$4.23Aug 29, 25$4.06Sep 3, 25$3.80Sep 5, 25$3.69Sep 9, 25$3.57Sep 11, 25$3.62Sep 16, 25$3.49Sep 18, 25$3.69Sep 22, 25$3.59Sep 24, 25$3.54Sep 26, 25$3.48Sep 30, 25$3.44Oct 2, 25$3.31Oct 6, 25$3.36Oct 8, 25$3.47Oct 10, 25$3.20Oct 14, 25$3.33Oct 16, 25$3.45Oct 21, 25$5.16Oct 23, 25$5.21Oct 27, 25$5.17Oct 29, 25$5.04Oct 31, 25$5.06Nov 4, 25$4.98Nov 6, 25$5.00Nov 10, 25$6.52Nov 12, 25$7.72Nov 14, 25$7.11Nov 18, 25$7.14Nov 20, 25$6.64Nov 25, 25$8.10Nov 28, 25$8.36Dec 2, 25$8.30Dec 4, 25$8.34Dec 8, 25$8.53Dec 10, 25$8.46Dec 12, 25$8.10Dec 16, 25$8.39Dec 18, 25$8.26Dec 22, 25$8.44Dec 24, 25$9.05Dec 29, 25$8.64Jan 2, 26$7.48Jan 6, 26$7.47Jan 8, 26$7.53Jan 12, 26$7.41Jan 14, 26$6.89Jan 16, 26$6.47Jan 21, 26$6.38Jan 23, 26$6.02Jan 27, 26$6.02Jan 29, 26$6.15Feb 2, 26$6.44Feb 4, 26$6.12Feb 9, 26$5.94Feb 11, 26$5.53Feb 13, 26$5.36Feb 18, 26$5.26Feb 20, 26$5.40Feb 24, 26$5.25Feb 26, 26$5.32Mar 2, 26$5.62Mar 4, 26$5.41Mar 6, 26$3.71Mar 10, 26$4.01Mar 12, 26$3.62Mar 17, 26$3.89Mar 19, 26$3.57Mar 23, 26$3.63Mar 25, 26$4.04Mar 27, 26$3.88Mar 31, 26$3.77Apr 2, 26$3.52Apr 7, 26$3.50Apr 9, 26$3.50Apr 13, 26$3.69Apr 15, 26$3.91Apr 17, 26$4.09Apr 22, 26$4.27Apr 24, 26$4.36Apr 28, 26$4.36Apr 30, 26$4.09May 4, 26$4.22May 6, 26$4.30May 8, 26$5.38May 12, 26$4.93May 14, 26$5.20May 18, 26$4.86May 20, 26$4.86May 22, 26$5.03May 28, 26$5.06Jun 1, 26$4.54Jun 3, 26$4.34Jun 5, 26$4.45Jun 9, 26$4.85Jun 11, 26$4.79Jun 15, 26$5.02Jun 17, 26$5.01Jun 22, 26$5.24Jun 24, 26$5.50Jun 26, 26$5.69Jul 2, 26$5.45
$3.2052-week range$9.05
Loading valuation history…

Fundamentals

Key fundamentals

$270.1M

Market cap

-3.1%

Revenue growth (YoY)

86.2%

Gross margin

-$29.9M

Free cash flow (USD)

-$51.2M

Net debt

Net cash position

4.0%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$7.5MFY 2019$23.3MFY 2020$27.6MFY 2021$49.0MFY 2022$71.3MFY 2023$81.1MFY 2024$79.9MFY 2025$77.4M
$7.5M$77.4M

Free cash flow by year

2018 → 2025

FY 2018$-15.0MFY 2019$-25.7MFY 2020$-33.1MFY 2021$-53.4MFY 2022$-76.9MFY 2023$-48.0MFY 2024$-22.7MFY 2025$-29.9M
-$15M-$29.9M

Gross margin by year

2021 → 2025

FY 202182.4%FY 202282.7%FY 202385.3%FY 202485.5%FY 202586.2%
82.4%86.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

1

Insider buys · 90 days

3

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $69KEncrantz Staffan · Director, 10% Owner · $68.8KJun 11, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 5, 2026Filing
  • Insider sellInsider Sell $65KBauerlein Alison · Chief Operating Officer · $65.2KMay 19, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventPatent Infringement JudgmentApr 23, 2026Filing
  • Insider sellInsider Sell $49KHAYDEN JEREMY B. · Chief Legal Officer · $48.9KApr 9, 2026Filing
  • Insider sellInsider Sell $26KRodberg James · Chief Financial Officer · $25.7KApr 9, 2026Filing
  • Insider sellInsider Sell $108KBadawi Paul · Director, President and CEO, 10% Owner · $108.2KApr 3, 2026Filing
  • Insider sellInsider Sell $11KTaylor Brenton · EVP, Operations & R&D · $10.6KApr 3, 2026Filing

Questions

Frequently asked questions

What is Sight Sciences, Inc.'s market cap?

Sight Sciences, Inc. (SGHT) has a market capitalization of $270.1M.

What is SGHT's P/E ratio?

A meaningful P/E ratio is not available for SGHT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SGHT's price-to-book (P/B) ratio?

SGHT trades at 4.22 times book value per share.

Are insiders buying SGHT stock?

Yes — SEC Form 4 filings show 1 open-market insider buy and 3 sells at Sight Sciences, Inc. in the last 90 days.

Same arena

Related companies in Medical - Devices

SENS

Senseonics Holdings, Inc.

$280.3M

CATX

Perspective Therapeutics, Inc.

$310.2M

RXST

RxSight, Inc.

$228.9M

AVR

Anteris Technologies Global Corp.

$314.1M

ELMD

Electromed, Inc.

$318.5M

TMCI

Treace Medical Concepts, Inc.

$218.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.